Follow
Checkpoint inhibitors beyond cancer: targets for restoring CD8 T cell function in people living with HIV.
"Our results demonstrated a marked and significant increase in TIGIT CD8+ T-cells, particularly within the central memory compartment, not ameliorated by long-term ART."
